News
게시물 상세
Pioneering Breakthroughs in Biotechnology for Advanced Adjuvant Platforms
작성일 : 2023.08.03

Progeneer, a prominent Korean start-up, is creating a wave in the biotechnology sector with its revolutionary vaccine adjuvants and cell-free protein synthesis technologies. Their vaccine adjuvants play a crucial role in enhancing the effectiveness of vaccines by stimulating the immune response.

"Our revolutionary technologies in vaccine adjuvants and cell-free protein synthesis are driving innovation in the biotechnology industry. With a focus on personalized cancer vaccines and advanced adjuvant platforms, we are filling crucial gaps and revolutionizing the fight against diseases," says Chul Kim, CEO.....

 

URL: https://www.startupcity.com/progeneer

 

이전글 서울바이오허브, 스위스 네트워킹 데이 성료… 유망 바이오 스타트업 해외 진출 지원
다음글 프로지니어, 조건부활성 '新면역증강' 항암백신 개발

Sitemap닫기

About Us
Our Identity
Leadership
Contact us
Science and Technology
CFPS
Lipid Nano Platform
Publications
Media
News
Notices
Careers
Job Opportunities